Data / Form D filings / AOA DX Inc.
AOA DX Inc.: Form D filings
AOA DX Inc., a biotechnology company in Denver, CO, filed 5 Form D notices with the SEC between 2021 and 2025. The latest, on October 15, 2025, reports $8.1 million sold of a $30.6 million offering to 40 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6860 Broadway, Unit B, Denver, CO, 80221
- Phone
- (617) 903-0350
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1869920
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | New notice | $30,582,903 | $8,085,364 | $22,497,539 | 40 | Oct 1, 2025 | sec.gov |
| Dec 19, 2024 | New notice | $7,500,000 | $1,845,060 | $5,654,940 | 15 | Dec 5, 2024 | sec.gov |
| Jul 26, 2023 | New notice | $24,188,865 | $23,611,721 | $577,144 | 119 | Jul 11, 2023 | sec.gov |
| Nov 18, 2021 | New notice | $5,000,000 | $2,639,450 | $2,360,550 | 33 | Nov 3, 2021 | sec.gov |
| Jul 7, 2021 | New notice | $2,500,000 | $2,500,000 | 38 | Feb 26, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Surbhi Sarna | Director | |
| Anna Milik Jeter | Executive Officer | |
| Abigail James Mcelhinny | Executive Officer | |
| Oriana Papin-Zoghbi | Executive Officer, Director | |
| John Friedman | Director | |
| Alexander James Fisher | Executive Officer |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Oct 13, 2025 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AOA DX Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.